Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03913273 · ClinicalTrials.gov registry record · NA
Agonist-Antagonist Myoneural Interface for Functional Limb Restoration After Transtibial Amputation
A NA study, sponsored by Massachusetts Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT03913273 is a NA study that has completed, run by Massachusetts Institute of Technology. The registered enrollment target is 14 participants.
The verdict
NCT03913273, a NA study, has completed, sponsored by Massachusetts Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study involves the functional testing of a new lower extremity prosthesis by healthy, active participants with fully healed transtibial (below knee) amputations. The study design calls for an experimental group of eleven participants who received two agonist-antagonist myoneural interfaces (AMIs) that were surgically constructed during a modified transtibial amputation procedure, and a control group of eleven matched participants who received standard transtibial amputations. The study protocol involves one or more of the following activities: 1. Collection of electromyography (EMG) data from participants' lower limbs to characterize muscle activation and create maps specific to individual participants, 2. Investigation of participants' capabilities to use a new lower extremity prosthesis that is designed to allow independent actuation of the ankle and subtalar joints, and offers EMG-modulated control over prosthetic joint position and stiffness, and 3. Exploration of AMIs as a means of communicating information between the participant and the new prosthesis using an experimental system involving EMG, functional electrical stimulation, and ultrasound. The hypothesis is that transtibial amputations involving AMIs can offer improved motor control of the new prosthesis while also enabling proprioceptive sensation (perception of the position, movement, and torque of the affected limb and prosthetic joint). The AMIs are expected to improve voluntary prosthetic control, improve prosthetic terrain adaptations, and offer new possibilities for bi-directional communication across the human-device interface.
Interventions
- PROCEDURE AMI transtibial amputation
- PROCEDURE Standard transtibial amputation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2025-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03913273
The ClinicalTrials.gov registry entry for NCT03913273 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts Institute of Technology, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AMI transtibial amputation is the first listed.
NCT03913273 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03913273 about?
NCT03913273 is a clinical study titled "Agonist-Antagonist Myoneural Interface for Functional Limb Restoration After Transtibial Amputation". This study involves the functional testing of a new lower extremity prosthesis by healthy, active participants with fully healed transtibial (below knee) amputations. The study design calls for an experimental group of eleven participants who received two agonist-antagonist myoneural interfaces (AMI...
What is the current status of trial NCT03913273?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2019-06-12. Estimated completion is 2025-06-01.
What interventions are being tested in trial NCT03913273?
The interventions under investigation include: AMI transtibial amputation (PROCEDURE), Standard transtibial amputation (PROCEDURE).
Who is sponsoring clinical trial NCT03913273?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.